Business · 30/05/2025
FDA Clears Way for ursodiol Capsule Approval
The FDA has determined that the 150mg ACTIGALL (ursodiol) capsule was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →